Relevium Technologies Inc. (TSXV:RLV) entered into a binding agreement to acquire Sleipnir Nutrition Ltd. for $0.14 million on January 23, 2019. Pursuant to the terms of agreement, Relevium Technologies will pay $0.035 million in cash at closing, $0.1 million is payable in shares out of which $0.05 million will be paid after six months of closing and $0.05 million will be paid after twelve months of closing. Relevium Technologies will also assume a debt of $0.26 million. Post-completion, Holly Llewellyn, Sleipnir founder and President will joins Relevium in a key leadership role. The transaction is subject to regulatory approval by the TSX Venture Exchange and consummation of due diligence. The expected closing of the transaction is before the end of of January 2019. The transaction is expected to accretive immediately in terms of revenue.